(Q50512990)

English

Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas?

scientific article published in March 2000

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

Concurrent Ki-67 and p53 immunolabeling in cutaneous melanocytic neoplasms: an adjunct for recognition of the vertical growth phase in malignant melanomas? (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

5

object named as

Swanson PE

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

7

object named as

Wick MR

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

author name string

Kaleem Z

1

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

Lind AC

2

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

Humphrey PA

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

Sueper RH

4

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

Ritter JH

6

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

publication date

1 March 2000

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

Modern Pathology

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

13

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

3

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

217-222

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

https://scigraph.springernature.com/pub.10.1038/modpathol.3880040

0 references

Nuclear morphometry, immunohistochemical staining with Ki-67 antibody and mitotic index in the assessment of proliferative activity and prognosis of primary malignant melanomas of the skin.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

21 January 2018

Loss of expression of the p16INK4/CDKN2 gene in cutaneous malignant melanoma correlates with tumor cell proliferation and invasive stage.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

21 January 2018

Comparison of proliferative activity as assessed by proliferating cell nuclear antigen (PCNA) and Ki-67 monoclonal antibodies in melanocytic skin lesions. A quantitative immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

21 January 2018

Kl 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

21 January 2018

Melanoma in situ versus melanocytic hyperplasia in sun-damaged skin. Assessment of the significance of histopathologic criteria for differential diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

21 January 2018

MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

21 January 2018

Nevoid malignant melanoma: morphologic patterns and immunohistochemical reactivity.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

21 January 2018

Bivariate flow cytometric analysis of DNA content versus immunopositivity for ribonucleotide reductase M1 subunit in the cell cycle.

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

21 January 2018

p53 Protein Expression in Nevi and Melanomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferative activities in Spitz nevus compared with melanocytic nevus and malignant melanoma using expression of PCNA/cyclin and mitotic rate

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferative activity of cutaneous melanocytic tumors defined by Ki-67 monoclonal antibody. A quantitative immunohistochemical study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferation marker Ki-S5 as a diagnostic tool in melanocytic lesions

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

p53-protein and Ki-67-antigen expression are both reliable biomarkers of prognosis in thick stage I nodular melanomas of the skin

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

MIB-1 proliferative activity is a significant prognostic factor in primary thick cutaneous melanomas

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferating cell nuclear antigen staining in deep-penetrating nevi

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Expression of proliferating cell nuclear antigen in Spitz nevus

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Proliferative activity of cutaneous melanocytic neoplasms defined by a proliferating cell nuclear antigen labelling index

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunohistochemical study of Spitz nevi and malignant melanoma with use of antibody to proliferating cell nuclear antigen

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors for cutaneous melanoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Malignant melanoma within an intradermal nevus

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3880040

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/MODPATHOL.3880040

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 March 2018

http://europepmc.org/abstract/MED/10757331

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50512990&oldid=1791921456"